Cargando…

Soporte circulatorio con ECMO venoarterial en paciente con cardiomiopatía de Takotsubo biventricular

Takotsubo cardiomyopathy is an entity characterized by acute and transient ventricular dysfunction, which is usually related to a triggering event (emotional or physical stress), and usually presents with regional systolic dysfunction of the left ventricle, however up to 30% may be biventricular. De...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazcano-Díaz, Emmanuel A., González-Ruíz, Francisco J., Sarre-Álvarez, Diego, Álvarez-Álvarez, Rolando J., Bucio-Reta, Eduardo, García-Cruz, Edgar, Rojas-Velasco, Gustavo, Ramos-Enríquez, Ángel, Melano-Carranza, Efrén, Santos-Martínez, Luis E., Baranda-Tovar, Francisco M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Permanyer Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258904/
https://www.ncbi.nlm.nih.gov/pubmed/33008148
http://dx.doi.org/10.24875/ACM.20000038
Descripción
Sumario:Takotsubo cardiomyopathy is an entity characterized by acute and transient ventricular dysfunction, which is usually related to a triggering event (emotional or physical stress), and usually presents with regional systolic dysfunction of the left ventricle, however up to 30% may be biventricular. Depending on its severity in some cases the disease can condition refractory cardiogenic shock to management with inotropics and vasopressors, so for these cases circulatory assistance devices should be considered. We present the case of a young patient who had pulmonary valve change with biological prosthesis, which seven weeks after surgery went to the emergency department with pericardial effusion and tamponade physiology secondary to postpericardiotomy syndrome. For this reason pericardial window was practiced, however during the procedure she presented biventricular Takotsubo cardiomyopathy which conditioned cardiogenic shock with severe mitral and tricuspid regurgitation, and refractivity to medical treatment as well as intraaortic balloon pump, requiring circulatory support with venoarterial ECMO for 5 days.